目前，对lncRNA的研究受到了低通量的限制。最近，CRISPR筛选能够用于识别功能性的lncRNA，不过基于Cas9酶的CRISPR-Cas9系统在DNA水平上编辑基因时 ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

CRISPR stocks are high risk but hold potential for aggressive investors. CRISPR Therapeutics and its partner Vertex Pharmaceuticals have the only approved CRISPR therapy. Several other biotech ...

Algen Biotechnologies fuses cutting-edge gene editing clustered regularly interspaced short palindromic repeat (CRISPR ... and all intermediate stages drawn from human cohorts (Fig.

Versions of the species carrying Zika and dengue fever can be manipulated with CRISPR so that they give birth to sterile offspring, below. David Liittschwager Mosquito larvae in the laboratory of ...

"Unlike the well-known CRISPR gene-editing system, often described as molecular 'scissors,' the newly studied type IV-A CRISPR system does not cut genes. Instead, it uses an RNA-guided 'effector ...

But on November 25, the young Chinese researcher became the center of a global firestorm when it emerged that he had allegedly made the first CRISPR-edited babies, twin girls named Lulu and Nana.

Despite moving in opposite directions in 2024, CRISPR Therapeutics and Exelixis have strong prospects. CRISPR Therapeutics (CRSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing ...

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.

Scientists say they have successfully eliminated HIV from infected cells, using Nobel Prize-winning Crispr gene-editing technology. Working like scissors, but at the molecular level, it cuts DNA ...

At CRISPR Therapeutics AG, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 30.00K shares worth $1.67M, meanwhile, insiders have report ...